Literature DB >> 2171343

T-lymphocyte effects on murine cytomegalovirus pulmonary infection.

M Kadima-Nzuji1, J E Craighead.   

Abstract

Cytomegalovirus (CMV) infections were induced in male BALB/c mice treated with rat monoclonal antibodies (MAb) to deplete selectively CD8 and CD4 cell populations in vivo. The animals were then inoculated intraperitoneally with murine CMV and the infection was monitored virologically and histologically. High concentrations of virus were found in the lungs of mice depleted of CD4 or both CD4 and CD8 cells. These animals developed pulmonary infections that persisted for at least 49 days after inoculation. In contrast, immunologically intact mice and those administered anti-CD8 MAb experienced only a transient infection of the lungs. Focal interstitial infiltrates of mononuclear cells were demonstrated in pulmonary tissues of CD4 MAb-treated animals, but not in normal mice and those receiving the CD8 MAb. Adoptive transfer of CD4 cells to animals (rendered immune-incompetent by thymectomy and irradiation) protected against pulmonary infection and the development of interstitial pneumonia. Mice treated with CD4 MAb failed to produce specific CMV antibody, whereas the depletion of CD8 cells had no effect on antibody elaboration. Administration of anti-CD4 and CD8 MAb did not affect virus replication in the salivary glands, the preferential site for CMV infection in the mouse. Induction of pulmonary infection and interstitial pneumonia by CMV in BALB/c mice is mediated by CD4 T cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171343      PMCID: PMC1877540     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  28 in total

1.  THE INCIDENCE OF INFECTION WITH CYTOMEGALOVIRUS IN A NORMAL POPULATION. A SEROLOGICAL STUDY IN GREATER LONDON.

Authors:  H STERN; S D ELEK
Journal:  J Hyg (Lond)       Date:  1965-03

2.  Monocyte migration across pulmonary membranes in mice infected with cytomegalovirus.

Authors:  G F Murphy; A R Brody; J E Craighead
Journal:  Exp Mol Pathol       Date:  1975-02       Impact factor: 3.362

3.  Cytomegalovirus pulmonary disease.

Authors:  J E Craighead
Journal:  Pathobiol Annu       Date:  1975

4.  Pathogenesis of pulmonary cytomegalovirus infection in immunosuppressed mice.

Authors:  A R Brody; J E Craighead
Journal:  J Infect Dis       Date:  1974-06       Impact factor: 5.226

5.  Pulmonary cytomegalovirus infection in the adult.

Authors:  J E Craighead
Journal:  Am J Pathol       Date:  1971-06       Impact factor: 4.307

6.  Cytomegalovirus infection after renal allotransplantation.

Authors:  J E Craighead; J B Hanshaw; C B Carpenter
Journal:  JAMA       Date:  1967-09-04       Impact factor: 56.272

7.  A simple perfusion apparatus for lung fixation.

Authors:  A R Brody; J E Craighead
Journal:  Proc Soc Exp Biol Med       Date:  1973-06

8.  IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

Authors:  M Sarmiento; A L Glasebrook; F W Fitch
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

9.  Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus.

Authors:  M Ho
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

10.  Modification by adoptive humoral immunity of murine cytomegalovirus infection.

Authors:  J D Shanley; M C Jordan; J G Stevens
Journal:  J Infect Dis       Date:  1981-02       Impact factor: 5.226

View more
  2 in total

1.  CD4+ T-cell reconstitution reduces cytomegalovirus in the immunocompromised brain.

Authors:  Jon D Reuter; Jean H Wilson; Kimberly E Idoko; Anthony N van den Pol
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Distinct types of lung disease caused by functional subsets of antiviral T cells.

Authors:  W H Alwan; W J Kozlowska; P J Openshaw
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.